000			03056nam a22004335i 4500
001			978-3-642-12130-2
003			DE-He213
005			20140220084533.0
007			cr nn 008mamaa
008			100825s2010 gw | s |||| 0|eng d
020			_a9783642121302 _9978-3-642-12130-2
024	7		_a10.1007/978-3-642-12130-2 _2doi
050		4	_aRC254-282
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a616.994 _223
100	1		_aAlberts, David S. _eeditor.
245	1	0	_aIntraperitoneal Therapy for Ovarian Cancer _h[electronic resource] / _cedited by David S. Alberts, Mary C. Clouser, Lisa M. Hess.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2010.
300			_aVIII, 154p. 18 illus., 12 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aCurrent Chemotherapy of Ovarian Cancer -- Principles of Intraperitoneal Chemotherapy -- Intraperitoneal Chemotherapy: Phase III Trials -- Criteria for Using Intraperitoneal (IP) Chemotherapy for Advanced Ovarian Cancer -- Selection and Placement of Intraperitoneal Catheters for IP Chemotherapy for Ovarian Cancer -- Selection of Drugs for Intraperitoneal Chemotherapy for Ovarian Cancer -- Administration Guidelines for Intraperitoneal Chemotherapy for Ovarian Cancer -- Novel Drugs for Intraperitoneal Therapy for Ovarian Cancer -- Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: An Ongoing Research Effort -- Health-Related Quality of Life and Patient-Reported Outcomes.
520			_aIntraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.
650		0	_aMedicine.
650		0	_aOncology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aOncology.
700	1		_aClouser, Mary C. _eeditor.
700	1		_aHess, Lisa M. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642121296
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-12130-2
912			_aZDB-2-SME
999			_c112000 _d112000